Histogenics Priced, Nasdaq: HSGX
Developing a tissue implant to repair knee cartilage using regenerative medicine.
Industry: Health Care
First Day Return: +6.8%
HSGX
Developing a tissue implant to repair knee cartilage using regenerative medicine.
| IPO Data | |
|---|---|
| IPO Date | 12/02/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $65 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Waltham, MA, United States |
| Founded | 2000 |
| Employees at IPO | 42 |
| Website www.histogenics.com | |
IPO News for Histogenics
Histogenics (HSGX) Performance
